Interim Chief of Pediatric Hematology/Oncology at The Cancer Institute of New Jersey Named to National Clinical Trial Review Panel

Dr. Richard Drachtman Tapped for National Cancer Institute Board
September 15, 2009

New Brunswick, N.J. – The interim division chief of pediatric hematology/oncology at The Cancer Institute of New Jersey (CINJ), Richard Drachtman, MD, has been selected to serve on the National Cancer Institute (NCI) Pediatric Central Institutional Review Board (PedCIRB). CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Dr. Drachtman, who also is a professor of pediatrics at UMDNJ-Robert Wood Johnson Medical School, will serve on the 16-member panel, which reviews NCI-sponsored pediatric clinical trials conducted by the world’s largest pediatric cancer research entity known as the Children’s Oncology Group. The PedCIRB was created in 2004 as a means to further increase patient protection by assembling a group of pediatric cancer experts to review clinical trials before they are offered to patients. The expert panel includes pediatric oncologists, nurses, childhood cancer survivors and consumer advocates.

In addition to being the author of many articles, editorials and reviews, Drachtman -- who is widely recognized for his clinical expertise and research in childhood cancer and sickle cell disease -- has edited and authored numerous books and book chapters.

The East Brunswick resident, who has a specialty interest in Hodgkin’s disease, has been with CINJ for more than a decade.

About The Cancer Institute of New Jersey

The Cancer Institute of New Jersey is the state’s first and only National Cancer Institute-designated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, quite literally bringing research to life. The Cancer Institute of New Jersey is a center of excellence of UMDNJ-Robert Wood Johnson Medical School. To support CINJ, please call the Cancer Institute of New Jersey Foundation at 1-888-333-CINJ.

The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Flagship Hospital: Robert Wood Johnson University Hospital. Major Clinical Research Affiliate Hospitals: Carol G. Simon Cancer Center at Morristown Memorial Hospital, Carol G. Simon Cancer Center at Overlook Hospital, and Jersey Shore University Medical Center. Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, Cooper University Hospital*, JFK Medical Center, Mountainside Hospital, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ at Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School*, and University Medical Center at Princeton. *Academic Affiliate



Michele Fisher


precision medicine at Rutgers Cancer Institute







Donate Now








Proud member of
Big Ten Cancer Research Consortium



Rutgers Health